HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Santos Selected Research

A Santos Research Topics

Disease

5Osteoarthritis
09/2022 - 02/2020
5Neoplasms (Cancer)
09/2016 - 03/2001
3Body Weight (Weight, Body)
09/2022 - 09/2018
3Hip Osteoarthritis (Coxarthrosis)
09/2022 - 06/2021
3Pain (Aches)
09/2022 - 07/2006
3Obesity
12/2018 - 05/2013
3Cushing Syndrome
02/2017 - 07/2010
3Breast Neoplasms (Breast Cancer)
09/2016 - 11/2001
3Hypertension (High Blood Pressure)
07/2013 - 01/2000
2Alcoholism (Alcohol Abuse)
10/2023 - 04/2019
2Diarrhea
04/2022 - 07/2001
2Wounds and Injuries (Trauma)
02/2022 - 04/2009
2Weight Loss (Weight Reduction)
12/2018 - 05/2013
2Hypoxia (Hypoxemia)
01/2017 - 01/2000
2Parkinson Disease (Parkinson's Disease)
05/2015 - 02/2013
2Schizophrenia (Dementia Praecox)
01/2015 - 03/2003
2Infections
01/2014 - 05/2004
2Hypersensitivity (Allergy)
01/2011 - 06/2009
2Rheumatoid Arthritis
07/2010 - 01/2002
2Inflammation (Inflammations)
11/2009 - 04/2005
2Prostatic Neoplasms (Prostate Cancer)
12/2004 - 02/2002
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2024
1Liver Neoplasms (Liver Cancer)
09/2023
1COVID-19
06/2023
1Ulcerative Colitis
05/2023
1Osteophyte
09/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022
1Shock
06/2021
1Vasoplegia
06/2021
1Foreign Bodies (Foreign Body)
03/2020
1Hyperkinesis
04/2019
1Hypothyroidism
04/2019
1Non-alcoholic Fatty Liver Disease
12/2018
1Thrombosis (Thrombus)
11/2018
1Insulin Resistance
01/2018
1Sepsis (Septicemia)
01/2018
1Idiopathic Pulmonary Fibrosis
09/2017
1Disease Progression
09/2017
1Delirium
04/2017
1Carcinosarcoma
09/2016
1Cadaver (Cadavers)
12/2015

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
10/2023 - 10/2013
3Proteins (Proteins, Gene)FDA Link
01/2017 - 09/2004
3LipidsIBA
03/2012 - 01/2002
2Psyllium (Metamucil)IBA
04/2022 - 03/2021
2Stanozolol (Winstrol)FDA Link
01/2022 - 01/2021
2Hormones (Hormone)IBA
04/2019 - 04/2012
2Insulin (Novolin)FDA Link
01/2018 - 07/2013
2GlucocorticoidsIBA
06/2015 - 07/2010
2Phosphotransferases (Kinase)IBA
11/2001 - 03/2001
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2000 - 01/2000
2Phenylephrine (Neo-Synephrine)FDA LinkGeneric
01/2000 - 01/2000
2Oxygen (Dioxygen)IBA
01/2000 - 01/2000
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
05/2024
1Fibric Acids (Fibrates)IBA
05/2024
1obeticholic acidIBA
05/2024
1Naltrexone (ReVia)FDA LinkGeneric
10/2023
1R 121919IBA
10/2023
1mu Opioid Receptors (mu Opioid Receptor)IBA
10/2023
1SirtuinsIBA
09/2023
1polypyrroleIBA
06/2023
1Single-Domain AntibodiesIBA
06/2023
1nickel hydroxide (nickel(II)hydroxide)IBA
06/2023
1HMGB1 Protein (HMG1)IBA
05/2023
1C-Reactive ProteinIBA
09/2022
1Interleukin-1 (Interleukin 1)IBA
09/2022
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
08/2022
1Triamcinolone (Aristocort)FDA Link
08/2022
1AerosolsIBA
02/2022
1hylanIBA
01/2021
1triamcinolone hexacetonide (Aristospan)FDA Link
01/2021
1Biocompatible Materials (Biomaterials)IBA
03/2020
1Ethanol (Ethyl Alcohol)IBA
04/2019
1Thyroid HormonesIBA
04/2019
1EnzymesIBA
04/2019
1LiraglutideFDA Link
12/2018
1ParaffinIBA
11/2018
1ProgesteroneFDA LinkGeneric
09/2018
1diacereinIBA
01/2018
1Atorvastatin (Lipitor)FDA Link
01/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2017
1CortisoneFDA Link
02/2017
1CatalaseIBA
01/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1Glutathione (Reduced Glutathione)IBA
01/2017
1AntioxidantsIBA
01/2017
1Transaminases (Aminotransferases)IBA
01/2017
1SilverIBA
01/2017
1Adenosine Triphosphatases (ATPase)IBA
01/2017
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2016

Therapy/Procedure

8Therapeutics
05/2024 - 07/2001
2Radiotherapy
09/2023 - 06/2011
2Anesthesia
04/2017 - 01/2014
1Lasers (Laser)
04/2022
1Low-Level Light Therapy (LLLT)
04/2022
1Punctures
01/2018
1Ligation
01/2018
1Complementary Therapies (Alternative Medicine)
01/2018